Entyvio Pen 64764-0108
Generic: Vedolizumab
Product NDC
64764-0108- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 27, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761133
Need to source Entyvio Pen? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vedolizumab | 108 mg/.68mL |
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]
Packaging Options(1)
1 TRAY in 1 CARTON (64764-108-21) / 1 SYRINGE in 1 TRAY (64764-108-20) / .68 mL in 1 SYRINGE